Neurological adverse events of PD-1/PD-L1 immune checkpoint inhibitors in clinical trials: A meta-analysis
The authors first proposed the opinion that the incidence of serious NAEs in immunotherapy patients was significantly higher than in other groups, providing a novel direction for research.
Authors
- Hongyan Li (ORCID: https://orcid.org/0000-0002-2275-5039)
- Yanting Zhou (ORCID: https://orcid.org/0009-0005-0853-7480)
- Hansong Yu
Institutions
- Beijing Xuanwu Traditional Chinese Medicine Hospital (CN)
Publication Details
- Journal
- Clinics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.clinsp.2025.100698
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
- Beijing Municipal Natural Science Foundation